HSBC Holdings’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-75,544
| Closed | -$12.5M | – | 3258 |
|
|
2021
Q2 | $12.5M | Buy |
75,544
+13,947
| +23% | +$2.33M | 0.01% | 779 |
|
|
2021
Q1 | $9.45M | Buy |
61,597
+49,691
| +417% | +$6.75M | 0.01% | 822 |
|
|
2020
Q4 | $1.49M | Buy |
11,906
+907
| +8% | +$101K | ﹤0.01% | 1468 |
|
|
2020
Q3 | $1.11M | Buy |
10,999
+5,006
| +84% | +$510K | ﹤0.01% | 1503 |
|
|
2020
Q2 | $583K | Sell |
5,993
-1,638
| -21% | -$152K | ﹤0.01% | 1739 |
|
|
2020
Q1 | $636K | Sell |
7,631
-8,918
| -54% | -$870K | ﹤0.01% | 1665 |
|
|
2019
Q4 | $1.84M | Buy |
16,549
+2,773
| +20% | +$285K | ﹤0.01% | 1534 |
|
|
2019
Q3 | $1.37M | Buy |
13,776
+9,602
| +230% | +$954K | ﹤0.01% | 1795 |
|
|
2019
Q2 | $414K | Buy |
4,174
+158
| +4% | +$15.1K | ﹤0.01% | 2156 |
|
|
2019
Q1 | $443K | Hold |
4,016
| – | – | ﹤0.01% | 2165 |
|
|
2018
Q4 | $369K | Sell |
4,016
-3,489
| -46% | -$353K | ﹤0.01% | 2219 |
|
|
2018
Q3 | $827K | Buy |
7,505
+2,987
| +66% | +$311K | ﹤0.01% | 1824 |
|
|
2018
Q2 | $422K | Sell |
4,518
-1,046
| -19% | -$90.1K | ﹤0.01% | 2137 |
|
|
2018
Q1 | $462K | Sell |
5,564
-265
| -5% | -$23.5K | ﹤0.01% | 1969 |
|
|
2017
Q4 | $530K | Buy |
5,829
+1,054
| +22% | +$87.7K | ﹤0.01% | 1485 |
|
|
2017
Q3 | $364K | Hold |
4,775
| – | – | ﹤0.01% | 1858 |
|
|
2017
Q2 | $358K | Buy |
+4,775
| New | +$331K | ﹤0.01% | 1797 |
|
|
2017
Q1 | – | Sell |
-5,807
| Closed | -$320K | – | 2712 |
|
|
2016
Q4 | $320K | Buy |
+5,807
| New | +$319K | ﹤0.01% | 2183 |
|
Other funds holding PRAH
HSBC Holdings's PRAH Position: Q3 2021 in Review
HSBC Holdings sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 75,544 shares — an estimated $12.5M sold.
HSBC Holdings first reported a position in PRAH in Q4 2016 and held it in 18 quarters. The position peaked at $12.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- HSBC Holdings reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- HSBC Holdings sold 75,544 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $12.5M.
- HSBC Holdings first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 18 quarters.
- HSBC Holdings's PRA Health Sciences, Inc. position peaked at $12.5M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on HSBC Holdings's 13F filing for Q3 2021, filed 12 Nov 2021.